Literature DB >> 7618906

Psychosocial and clinical burden of thalassaemia intermedia and its implications for prenatal diagnosis.

S Ratip1, D Skuse, J Porter, B Wonke, A Yardumian, B Modell.   

Abstract

Twenty eight patients with thalassaemia intermedia and their parents were interviewed using specifically designed questionnaires to evaluate psychosocial burden. Hospital notes were analysed for clinical burden. A wide variation was found for both patients and parents, ranging from virtually unaffected to severely affected. Normal sexual function and setting up a family were mentioned by patients and parents as being particularly important for quality of life. Over half (58%) of the patients had problems with sexual maturation and functioning, and continuous monitoring of all patients with thalassaemia intermedia by a paediatric endocrinologist is therefore strongly indicated. Most parents said, in light of their experiences, that they would opt for prenatal diagnosis and termination of affected pregnancies even if a genotype predicting the mild form of disorder were discovered.

Entities:  

Mesh:

Year:  1995        PMID: 7618906      PMCID: PMC1511109          DOI: 10.1136/adc.72.5.408

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  13 in total

1.  COMPARISON OF SIXTY-SIX PATIENTS WITH THALASSEMIA MAJOR AND THIRTEEN PATIENTS WITH THALASSEMIA INTERMEDIA: INCLUDING EVALUATIONS OF GROWTH, DEVELOPMENT, MATURATION AND PROGNOSIS.

Authors:  M E ERLANDSON; R BRILLIANT; C H SMITH
Journal:  Ann N Y Acad Sci       Date:  1964-10-07       Impact factor: 5.691

2.  The molecular basis of thalassaemia major and thalassaemia intermedia in Asian Indians: application to prenatal diagnosis.

Authors:  S L Thein; C Hesketh; R B Wallace; D J Weatherall
Journal:  Br J Haematol       Date:  1988-10       Impact factor: 6.998

Review 3.  Thalassaemia intermedia.

Authors:  J S Wainscoat; S L Thein; D J Weatherall
Journal:  Blood Rev       Date:  1987-12       Impact factor: 8.250

4.  The molecular basis for the clinical diversity of beta thalassaemia in Cypriots.

Authors:  J S Wainscoat; J M Old; D J Weatherall; S H Orkin
Journal:  Lancet       Date:  1983-06-04       Impact factor: 79.321

5.  Molecular basis for mild forms of homozygous beta-thalassaemia.

Authors:  D J Weatherall; L Pressley; W G Wood; D R Higgs; J B Clegg
Journal:  Lancet       Date:  1981-03-07       Impact factor: 79.321

6.  A scaled version of the General Health Questionnaire.

Authors:  D P Goldberg; V F Hillier
Journal:  Psychol Med       Date:  1979-02       Impact factor: 7.723

7.  A children's behaviour questionnaire for completion by teachers: preliminary findings.

Authors:  M Rutter
Journal:  J Child Psychol Psychiatry       Date:  1967-05       Impact factor: 8.982

8.  Thalassaemia intermedia in Cyprus: the interaction of alpha and beta thalassaemia.

Authors:  J S Wainscoat; E Kanavakis; W G Wood; E A Letsky; E R Huehns; G W Marsh; D R Higgs; J B Clegg; D J Weatherall
Journal:  Br J Haematol       Date:  1983-03       Impact factor: 6.998

9.  Interaction between homozygous beta (0) thalassaemia and the Swiss type of hereditary persistence of fetal haemoglobin.

Authors:  M D Cappellini; G Fiorelli; L F Bernini
Journal:  Br J Haematol       Date:  1981-08       Impact factor: 6.998

10.  The spectrum of beta-thalassaemia mutations in Sicily.

Authors:  R Di Marzo; C E Dowling; C Wong; A Maggio; H H Kazazian
Journal:  Br J Haematol       Date:  1988-07       Impact factor: 6.998

View more
  10 in total

Review 1.  Psychological therapies for thalassaemia.

Authors:  Kofi A Anie; Pia Massaglia
Journal:  Cochrane Database Syst Rev       Date:  2014-03-06

2.  Managing the need to tell: Triggers and strategic disclosure of thalassemia major in Singapore.

Authors:  Neha Kumar; Erin Turbitt; Barbara B Biesecker; Ilana M Miller; Breana Cham; Katherine C Smith; Rajiv N Rimal
Journal:  Am J Med Genet A       Date:  2019-03-01       Impact factor: 2.802

3.  Psychosocial burden in thalassemia.

Authors:  Atika Khurana; Sudha Katyal; R K Marwaha
Journal:  Indian J Pediatr       Date:  2006-10       Impact factor: 1.967

4.  Psychometric properties of the Specific Thalassemia Quality of Life Instrument for adults.

Authors:  Georgios N Lyrakos; Demetra Vini; Helen Aslani; Marouso Drosou-Servou
Journal:  Patient Prefer Adherence       Date:  2012-07-02       Impact factor: 2.711

5.  Predictors of anxiety and depression in Egyptian thalassemic patients: a single center study.

Authors:  Sohier Yahia; Mohamed Adel El-Hadidy; Abdel-Hady El-Gilany; Rokiah Anwar; Ahmad Darwish; A K Mansour
Journal:  Int J Hematol       Date:  2013-04-18       Impact factor: 2.490

6.  Psychosocial aspects and psychiatric disorders in young adult with thalassemia major.

Authors:  Giuseppina Messina; Elisa Colombo; Elena Cassinerio; Francesca Ferri; Rita Curti; Carlo Altamura; Maria Domenica Cappellini
Journal:  Intern Emerg Med       Date:  2008-06-13       Impact factor: 3.397

7.  Pregnant women affected by thalassemia major: a controlled study of traits and personality.

Authors:  Giuseppina Messina; Elisa Colombo; Elena Cassinerio; Claudia Cesaretti; Alessia Marcon; Laura Zanaboni; Marina Baldini; Maria Domenica Cappellini
Journal:  J Res Med Sci       Date:  2010-03       Impact factor: 1.852

Review 8.  The impact of iron overload and its treatment on quality of life: results from a literature review.

Authors:  Linda Abetz; Jean-Francois Baladi; Paula Jones; Diana Rofail
Journal:  Health Qual Life Outcomes       Date:  2006-09-28       Impact factor: 3.186

9.  Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in β-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results from the EPIC Clinical Trial.

Authors:  John Porter; Donald K Bowden; Marina Economou; Jacques Troncy; Arnold Ganser; Dany Habr; Nicolas Martin; Adam Gater; Diana Rofail; Linda Abetz-Webb; Helen Lau; Maria Domenica Cappellini
Journal:  Anemia       Date:  2012-08-12

10.  Quality of life in patients with thalassemia major.

Authors:  Sh Ansari; A Baghersalimi; A Azarkeivan; M Nojomi; A Hassanzadeh Rad
Journal:  Iran J Ped Hematol Oncol       Date:  2014-04-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.